Harvard Bioscience Inc

HBI

Company Profile

  • Business description

    Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

  • Contact

    84 October Hill Road
    HollistonMA01746
    USA

    T: +1 508 893-8999

    E: [email protected]

    https://www.harvardbioscience.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    355

Stocks News & Analysis

stocks

Production increase on track for ASX hydrocarbon producer

Our view after lower earnings.
stocks

Market pricing in further upside in overvalued ASX bank

We view the shares are materially overvalued.
stocks

Chart of the Week: Lithium is rebounding on rising demand

The mining sector is significantly overvalued on average but select value to be found.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,316.6023.80-0.25%
CAC 408,361.5667.47-0.80%
DAX 4025,060.11218.10-0.86%
Dow JONES (US)49,662.66129.470.26%
FTSE 10010,617.8668.32-0.64%
HKSE26,705.94138.820.52%
NASDAQ22,753.63175.250.78%
Nikkei 22557,467.83323.990.57%
NZX 50 Index13,444.20197.181.49%
S&P 5006,881.3138.090.56%
S&P/ASX 2009,086.2024.30-0.27%
SSE Composite Index4,082.0751.95-1.26%

Market Movers